Table 2 A comparison of the clinical data between groups separated by the median level of FT3 (2.33 pg/mL).
FT3 ≤ 2.33 (pg/mL) (n = 314) | FT3 > 2.33 (pg/mL) (n = 311) | P value | |
---|---|---|---|
Male (%) | 80.6 | 92.6 | < 0.001 |
Age (years) | 70 (62, 76) | 63 (56, 71) | < 0.001 |
BMI (kg/m2) | 23.4 (21.5, 25.7) | 24.9 (22.8, 27.4) | < 0.001 |
SBP (mmHg) | 134 (118, 150) | 134 (114, 150) | 0.754 |
DBP (mmHg) | 68 (61, 76) | 72 (63, 81) | < 0.001 |
Heart rate (beats per minutes) | 74 (61, 85) | 71 (60, 83) | 0.549 |
Hb (g/dL) | 13.5 ± 1.84 | 14.4 ± 1.49 | < 0.001 |
eGFR (mL/min/1.73 m2) | 68.8 (59.5, 80.0) | 74.4 (65.4, 88.5) | < 0.001 |
Total bilirubin (mg/dL) | 0.8 (0.6, 0.9) | 0.8 (0.6, 1.0) | 0.010 |
Albumin (g/dL) | 3.84 ± 0.42 | 4.03 ± 0.32 | < 0.001 |
Fasting blood sugar (mg/dL) | 105 (94, 126) | 105 (94, 123) | 0.404 |
HbA1c (%) | 6.1 (5.7, 6.8) | 6.0 (5.7, 6.7) | 0.503 |
HDL (mg/dL) | 52 (41, 62) | 48 (41, 58) | 0.051 |
LDL (mg/dL) | 95 (76, 114) | 92 (75, 110) | 0.566 |
Triglyceride (mg/dL) | 91 (66, 130) | 110 (85, 147) | < 0.001 |
FT4 (ng/dL) | 1.24 ± 0.24 | 1.27 ± 0.22 | 0.102 |
TSH (μIU/mL) | 1.57 (0.98, 2.47) | 1.29 (0.83, 2.02) | < 0.001 |
BNP (pg/mL) | 52.1 (21.4, 139.7) | 25.7 (12.0, 64.0) | < 0.001 |
LVEF (%) | 60.1 (48.1, 66.1) | 61.5 (52.9, 66.0) | 0.093 |
LVESVI (mL/m2) | 24.2 (18.2, 35.4) | 23.3 (17.7, 32.6) | 0.104 |
LVEDVI (mL/m2) | 62.2 (50.9, 75.9) | 61.2 (49.3, 73.9) | 0.170 |